Source: NC BIOTECH, 6/7/21

North Carolina has seen consistent life sciences growth over the years, by offering a talented workforce, collaborative ecosystem and plenty of funding opportunities to businesses considering the state for their headquarters and expansions.

Despite the pandemic, 2020 clocked major numbers. And while the turn of the year to 2021 suggested a symbolic return to normalcy, North Carolina has surpassed all expectations in its life sciences announcements, approaching 2020’s excellent full-year numbers in only these first five months.

Not only has N.C. welcomed new sites for out-of-state businesses, but it has also secured significant reinvestments in the state’s existing companies. And BioAssets, or companies aiding the life sciences, have seen noteworthy growth as well.
Since the beginning of 2021, N.C. has hailed 15 announcements, reflecting $2.9+ billion in investment and the creation of 2,686 life sciences jobs, excluding jobs created in the construction and other related workforces. At this time last year, the state had seen five announcements bringing about 20% of this year’s investments. At this time in 2019, N.C. had seen eight announcements.

For more of this sotry, click here.